PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
Blue Cross & Blue Shield of MississippiAll Plans · Coverage · Medical Policy · Pulmonology, Physical TherapyMedium impact

Oscillatory Devices for the Treatment of Cystic Fibrosis and Other Respiratory Conditions

Effective date
Not stated in the notice
Identified
Jun 20, 2026

Summary

High-frequency chest wall compression devices and intrapulmonary percussive ventilation devices may be considered medically necessary in individuals with cystic fibrosis or chronic diffuse bronchiectasis when standard chest physical therapy has failed or is unavailable or not tolerated. An oscillatory positive expiratory pressure device may be considered medically necessary in individuals with hypersecretory lung disease who have difficulty clearing secretions and recurrent disease exacerbations. Other applications, including use as an adjunct to chest physical therapy and use in chronic obstructive pulmonary disease or respiratory conditions associated with neuromuscular disorders, are considered investigational.

Get alerts when payers change rules like this one

We check Blue Cross & Blue Shield of Mississippi and other payers every day and email you when a change matches your specialty and state.

Get Blue Cross & Blue Shield of Mississippi alertsPolicy Monitoring is free. No card required.

What to do

Action · 6 steps
01Billing team: For high-frequency chest wall compression devices and intrapulmonary percussive ventilation devices, document that the individual has cystic fibrosis or chronic diffuse bronchiectasis, that standard chest physical therapy has failed (frequent severe exacerbations of respiratory distress involving inability to clear mucus despite postural drainage and percussion) or is unavailable or not tolerated, and the chest computed tomography scan that the policy requires.
02Where the caregiver cannot perform standard treatment, document that as the valid reason standard treatment cannot be performed.
03For an oscillatory positive expiratory pressure device, document hypersecretory lung disease, difficulty clearing secretions, and recurrent disease exacerbations.
04For chronic diffuse bronchiectasis, document either a daily productive cough for at least 6 continuous months or exacerbations more than 2 times per year requiring antibiotic therapy, confirmed by high-resolution or spiral chest computed tomography scan.
05Do not bill these devices for other applications, including use as an adjunct to chest physical therapy, use in chronic obstructive pulmonary disease, or use for respiratory conditions associated with neuromuscular disorders, because the policy considers them investigational.
06Claims for services not documented to be medically necessary are not paid.

Codes mentioned

A7021A7025A7026E0469E0481E0483E0484S8185E84.9E84.0J47.0J47.1J47.9Q33.4

Original notice

Oscillatory Devices for the Treatment of Cystic Fibrosis and Other Respiratory Conditions
bcbsms.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account